Skip to main content
. 2022 Jul 25;10:946186. doi: 10.3389/fpubh.2022.946186

Table 1.

Baseline characteristics of the study population.

Characteristics Entire cohort PSM cohort
Non-GDM (n = 1679) GDM (n = 472) P -value SMD Non-GDM (n = 471) GDM (n = 471) P -value SMD
Maternal age, year 30.7 ± 4.2 32.4 ± 4.3 <0.001 0.381 32.4 ± 4.4 32.3 ± 4.2 0.682 0.027
Ethnicity
Han 1649 (98.2) 463 (98.1) 0.846 0.009 466 (98.9) 462 (98.1) 0.281 0.063
Others 30 (1.8) 9 (1.9) 5 (1.1) 9 (1.9)
Married
Yes 1620 (96.5) 448 (94.9) 0.118 - 461 (97.9) 447 (94.9) 0.014 -
No 59 (3.5) 24 (5.1) 10 (2.1) 24 (5.1)
Nulliparity
Yes 1165 (69.4) 324 (68.6) 0.758 0.016 313 (66.5) 323 (68.6) 0.487 0.046
No 514 (30.6) 148 (31.4) 158 (33.6) 148 (31.4)
Mode of conception
Spontaneous 485 (28.9) 105 (22.3) 0.004 0.153 102 (21.7) 105 (22.3) 0.813 0.015
ART 1194 (71.1) 367 (77.8) 369 (78.3) 366 (77.7)
Chorionicity
Dichorionic 406 (83.7) 416 (88.1) 0.019 0.127 420 (89.2) 415 (88.1) 0.608 0.031
Monochorionic 273 (16.3) 56 (11.9) 51 (10.8) 56 (11.9)
Maternal BMI
Underweight 278 (16.6) 36 (7.6) <0.001 0.226 283 (60.1) 287 (60.9) 0.514 0.024
Normal weight 1083 (64.5) 287 (60.8) 47 (10) 36 (7.6)
Overweight 260 (15.5) 105 (22.3) 105 (22.3) 104 (22.1)
Obese 58 (3.5) 44 (9.3) 36 (7.6) 44 (9.3)
Use of insulin
Yes - 30 (6.4) - - - 30 (6.4) - -
No - 442 (93.6) - 442 (93.6)
Chronic hypertension
Yes 11 (0.7) 9 (1.9) 0.012 - 7 (1.5) 9 (1.9) 0.614 -
No 1668 (99.3) 463 (98.1) 464 (98.5) 462 (98.1)
Hepatitis B
Yes 112 (6.7) 40 (8.5) 0.177 - 44 (9.3) 40 (8.5) 0.647 -
No 1567 (93.3) 432 (91.5) 427 (90.7) 431 (91.5)
ICP
Yes 45 (2.7) 13 (2.8) 0.930 - 16 (3.4) 13 (2.8) 0.571 -
No 1634 (97.3) 459 (97.3) 455 (96.6) 458 (97.2)
PIH or PE
Yes 168 (10.0) 55 (11.7) 0.300 - 56 (11.9) 54 (11.5) 0.839 -
No 1511 (90.0) 417 (88.4) 415 (88.1) 417 (88.5)
Fetal sex
Male-male 558 (33.2) 152 (32.2) 0.375 - 159 (33.8) 151 (32.1) 0.855 -
Female-female 481 (28.7) 124 (26.3) 120 (25.5) 124 (26.3)
Male-female 640 (38.1) 196 (41.5) 192 (40.8) 196 (41.6)

PSM, propensity score matching; ART, assisted reproductive technology; BMI, body mass index; ICP, intrahepatic cholestasis of pregnancy; PIH, pregnancy-induced hypertension; PE, preeclampsia.